Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 9.8T | 9.4T | 9.5T | 9.0T |
Cost of revenue | 2.1T | 2.2T | 2.1T | 2.0T |
Gross profit | 7.6T | 7.2T | 7.4T | 7.0T |
Operating expense | ||||
Research & development | 1.4T | 1.4T | 1.4T | 1.3T |
Selling general and admin | 4.0T | 3.9T | 4.0T | 3.8T |
Other operating expenses | — | — | — | — |
Operating income | 2.2T | 1.9T | 2.0T | 1.9T |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 66.7B | -3.8B | -123.9B | -193.6B |
Pretax income | 2.3T | 1.9T | 1.9T | 1.7T |
Tax provision | 494.8B | 412.8B | 267.0B | 208.8B |
Net income | 1.8T | 1.5T | 1.6T | 1.5T |
Basic EPS | 2.0 | 1.6 | — | 1.6 |
Diluted EPS | 2.0 | 1.6 | — | 1.6 |
Basic average shares | 911.5B | 915.3B | — | 911.5B |
Diluted average shares | 917.2B | 924.8B | — | 920.1B |
EBITDA | 3.0T | 2.8T | 3.0T | 2.9T |
Net income from continuing op. | 1.8T | 1.5T | 1.6T | 1.5T |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |